Sarah J. Chittenden
Downs Road, Surrey
Sutton Upon Derwent, ENG, United Kingdom
Sutton Upon Derwent, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
SOLLID - a single centre study to develop methods to investigate the effects of low radiation doses within nuclear medicine, to enable multicentre epidemiological investigations.
Journal: The British journal of radiology
Published: September 09, 2020
Standardised quantitative radioiodine SPECT/CT Imaging for multicentre dosimetry trials in molecular radiotherapy.
Journal: Physics in medicine and biology
Published: November 26, 2019
Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: March 19, 2019
Dosimetry-based treatment for Graves' disease.
Journal: Nuclear medicine communications
Published: April 04, 2018
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy.
Journal: The British journal of radiology
Published: January 03, 2018
Reply to 'Single high dose versus repeated bone-targeted radionuclide therapy'.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 17, 2017
Excretion and whole-body retention of radium-223 dichloride administered for the treatment of bone metastases from castration resistant prostate cancer.
Journal: Nuclear medicine communications
Published: December 01, 2017
A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases.
Journal: Physics in medicine and biology
Published: March 15, 2017
InfuShield: a shielded enclosure for administering therapeutic radioisotope treatments using standard syringe pumps.
Journal: Nuclear medicine communications
Published: February 11, 2017
The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 23, 2016
Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 24, 2016
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma.
Journal: Nuclear medicine communications
Published: January 28, 2016
Last Updated: 09/26/2026